Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor

Ryan M. Wyatt, Ian Fraser, Natalie Welty, Brian Lord, Michelle Wennerholm, Steven W. Sutton, Michael K. Ameriks, Christine Dugovic, Sujin Yun, Allison White,

Journal of Pharmacology and Experimental Therapeutics · 2019 · 29 citations · 75 references

DOIFull text

Open access

Concepts

References

75